Canada issues SLN (sentinel lymph node) breast biopsy guidance
This article was originally published in Clinica
Positive sentinel lymph node (SLN) biopsy results should prompt full axillary dissection, says Canada's steering committee for the care and treatment of breast cancer, in its latest guidance on SLN biopsy. Among the committee's nine recommendations are calls for SLN biopsy not to be carried out in women with clinically palpable nodes, locally advanced breast cancer, multifocal tumours, previous breast surgery or previous irradiation of the breast.
You may also be interested in...
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.
Netherlands' Authority for Consumers and Markets has reprimanded a dietary supplements player for purchasing fake followers and likes on social media to exaggerate the popularity of its products. It is the first case of its kind in the country.